{
  "component_scores": {
    "joint_involvement": {
      "score": 0,
      "justification": "Based on the patient facts, no specific joint counts are provided and should be scored as minimum plausible score (0 points)."
    },
    "serology": {
      "score": 3,
      "justification": "RF is positive at a value of 87 UI/mL which falls into high-positive category (3 points) according to the guidelines. Anti-CCP is also positive at a value of 67 U/mL and it's considered as anti-citrullinated protein antibodies (ACPA)."
    },
    "acute_phase": {
      "score": 1,
      "justification": "CRP level is 114 mg/L which is abnormal and falls into the category where an abnormal CRP OR ESR/VAHS marker is scored as 1 point. The VHS value of 43 mm/h is unknown but considered in the score calculation."
    },
    "duration": {
      "score": 0,
      "justification": "No information on disease duration provided, hence minimum plausible score (0 points)."
    }
  },
  "acr_eular_total": 7,
  "treatment_context": {
    "has_dmard": true,
    "treatment_strength": "strong",
    "justification": "Presence of methotrexate in treatment context is strong evidence of established RA."
  },
  "final_label": "RA+",
  "classification_rationale": "The patient meets the ACR/EULAR 2010 criteria for Rheumatoid Arthritis. They have scored a total of 7 points, which falls into the RA+ category. Given the presence of methotrexate in treatment context (strong evidence of established RA), the final label is 'RA+' with high confidence.",
  "confidence": "high",
  "patient_id": "5",
  "agent": "Agent2_v3_RAG_Guidelines",
  "rag_guidelines": {
    "query": "serology RF rheumatoid factor thresholds serology anti-CCP ACPA thresholds acute phase CRP inflammation thresholds acute phase ESR VHS inflammation thresholds joint involvement polyarthritis small joints MCPs PIPs treatment DMARD methotrexate ACR EULAR classification criteria interpretation scoring",
    "sections_retrieved": [
      "serology",
      "acute_phase_reactants",
      "joint_involvement",
      "treatment_context"
    ],
    "relevance_scores": [
      13.437418455637742,
      12.564144450970117,
      8.092676749040749,
      5.153478439892983
    ]
  },
  "guideline_citation": "Aletaha D, et al. Arthritis Rheum. 2010;62(9):2569-2581",
  "evidence_trace": [
    {
      "type": "disease_mention",
      "stay_id": "",
      "line_no": "007",
      "snippet": "Diagnostic : polyarthrite rhumatoïde confirmée."
    },
    {
      "type": "disease_mention",
      "stay_id": "",
      "line_no": "007",
      "snippet": "Diagnostic : polyarthrite rhumatoïde confirmée."
    },
    {
      "type": "disease_mention",
      "stay_id": "S0009",
      "line_no": 7,
      "snippet": "Diagnostic : polyarthrite rhumatoïde confirmée."
    },
    {
      "type": "lab",
      "test": "RF",
      "stay_id": "",
      "line_no": "004",
      "snippet": "RF : positif (142 UI/mL)."
    },
    {
      "type": "lab",
      "test": "anti-CCP",
      "stay_id": "",
      "line_no": "004",
      "snippet": "anti-CCP : positif (65 U/mL)."
    },
    {
      "type": "lab",
      "test": "CRP",
      "stay_id": "",
      "line_no": "003",
      "snippet": "Laboratoire (J1) : CRP 38 mg/L, VHS 43 mm/h, NFS normale."
    },
    {
      "type": "lab",
      "test": "VHS",
      "stay_id": "S0009",
      "line_no": 3,
      "snippet": "Laboratoire (J1) : CRP 38 mg/L, VHS 43 mm/h, NFS normale."
    },
    {
      "type": "drug",
      "name": "méthotrexate",
      "stay_id": "",
      "line_no": "008",
      "snippet": "Prise en charge : continuation de méthotrexate 20 mg/semaine + acide folique 5 mg/j."
    },
    {
      "type": "drug",
      "name": "methotrexate",
      "stay_id": "S0009",
      "line_no": 8,
      "snippet": "Prise en charge : continuation de méthotrexate 20 mg/semaine + acide folique 5 mg/j."
    }
  ],
  "component_scores_det": {
    "joint_involvement": 0,
    "serology": 3,
    "acute_phase": 1,
    "duration": 1
  },
  "acr_eular_total_det": 5,
  "det_label": "RA−",
  "has_dmard_det": true,
  "has_biologic_or_jak_det": false,
  "llm_vs_det_disagree": true,
  "override_applied": false
}